AARD vs GOOGL · $284.4M cap vs P/E 26, rev $229.69B
Aardvark Therapeutics, Inc. Common Stock (AARD) versus Alphabet Inc Class A (GOOGL) — a side-by-side from cached financials, not a winner call.
Aardvark Therapeutics, Inc. Common Stock (AARD) is a biotechnology company listed on US.
Alphabet Inc Class A (GOOGL) is a internet content & information company listed on US. It is led by Sundar Pichai.
Latest reported AARD revenue for 2025-12-31 was $0. Net income was -$57.6M. Revenue was down 100.0% from 2024-12-31 to 2025-12-31. AARD currently screens at market cap $284.4M.
Latest reported GOOGL revenue for 2026-06-30 was $229.69B. Net income was $174.77B. Revenue was up 23.1% from 2025-06-30 to 2026-06-30. GOOGL currently screens at market cap $2.97T and trailing P/E 26.1.
AARD currently screens at market cap $284.4M. GOOGL currently screens at market cap $2.97T and trailing P/E 26.1.
Not investment advice. Open the AARD and GOOGL stock pages for the full models.
Not investment advice.